The enterprise capital funding quantity raised by European
life sciences corporations from U.S. traders has skilled a unprecedented
development to this point. As of finish of August 2021, the gross quantity quantities to EUR 3.1bn,
which has already exceeded the amount of the entire 12 months 2020 by 24% (EUR
2.5bn).
Nevertheless, the variety of offers with U.S. participation
solely quantities to 134 in 2021 to this point which continues to be beneath the full variety of
2020 (157 offers).
 It’s notable that the variety of bigger offers with
U.S. participation has considerably elevated inside the final years. The
variety of offers with a quantity > EUR 30m amounted to 21 in 2018 and 22 in
2019. In 2020, it elevated to 38. As of finish of August 2021, there have already
been 53 fundraisings on this vary, confirming the development in direction of bigger
financing rounds within the life sciences sector.Â